每年研究計畫
個人檔案
學歷
- 1996 德國雷根斯堡大學藥學博士
- 1987 國防醫學院藥學研究所碩士
- 1985 國防醫學院藥學系學士
經歷
- 2018- 臺北醫學大學癌症生物學與藥物研發研究所教授
- 2018- 奈米醫學工程研究所教授
- 2014-2018 臺北醫學大學癌症生物學與藥物研發博士學位學程教授
- 2013-2014 臺北醫學大學藥物科學學科教授
- 2006-2007 臺北醫學大學生藥學研究所教授
- 2002-2006 臺北醫學大學生藥學研究所教授副教授
獎項
- Editorial Board:
- International Journal of Advanced Chemistry (IJAC)
- International Journal of Organic Chemistry
- Der Pharma Chemica
- Journal of Chemical Science and Technology
- Advances in Organic Chemistry (AOC)
- Journal of Bone Marrow and Stem Cell Research
- Journal of Natural Products Research Updates
- Innovational: Journal of Chemistry (IJChem)
- International Journal of Biological Instrumentation
- Asian Council of Science
- Editorial Advisory Board:
- The Open Cancer Journal (ISSN: 1874-0790)
- Recent Patent Reviews on Anti-cancer Drug Discovery
- Outstanding reviewer:
- Outstanding reviewer: Bioorganic & Medicinal Chemistry
- Outstanding reviewer: European Journal of Medicinal Chemistry
研究興趣
- 新藥開發設計合成
- 藥物化學
- 抗癌藥物開發研發
- 抗發炎及風免藥物開發研究
URL
指紋 查看啟用 Hsu-Shan Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 5 類似的檔案
Anthraquinones
Medicine & Life Sciences
Derivatives
Chemical Compounds
Telomerase
Medicine & Life Sciences
Cells
Chemical Compounds
Anthracenes
Medicine & Life Sciences
Anthralin
Medicine & Life Sciences
Antineoplastic Agents
Medicine & Life Sciences
Cytotoxicity
Chemical Compounds
網絡
國家層面的近期外部合作。點選圓點深入探索詳細資料。
研究計畫 2014 2020
研究成果 1988 2019
A novel multi-target small molecule, LCC-09, inhibits stemness and therapy-resistant phenotypes of glioblastoma cells by increasing MIR-34a and deregulating the DRD4/AKT/MTOR signaling axis
Wen, Y. T., Wu, A. T., Bamodu, O. A., Wei, L., Lin, C. M., Yen, Y., Chao, T. Y., Mukhopadhyay, D., Hsiao, M. & Huang, H. S., 十月 1 2019, 於 : Cancers. 11, 10, 1442.研究成果: 雜誌貢獻 › 文章
開啟存取
temozolomide
Glioblastoma
Phenotype
Glioma
Stem Cells
A novel salicylanilide derivative induces autophagy cell death in castration-resistant prostate cancer via ER stress-activated PERK signaling pathway
Hsieh, C-L., Huang, H-S., Chen, K-C., Saka, T., Chiang, C-Y., Chung, L. W. K. & Sung, S-Y., 九月 17 2019, 於 : Molecular Cancer Therapeutics.研究成果: 雜誌貢獻 › 文章
Castration
Autophagy
Prostatic Neoplasms
Cell Death
Osteogenesis
1
引文
(Scopus)
Anti-inflammatory and anti-osteoarthritis effects of Cm-02 and Ck-02
Ho, Y. J., Lu, J. W., Ho, L. J., Lai, J. H., Huang, H. S., Lee, C. C., Lin, T. Y., Lien, S. B., Lin, L. C., Chen, L. W., Gong, Z., Shen, M. C. & Liu, F. C., 九月 10 2019, 於 : Biochemical and Biophysical Research Communications. 517, 1, p. 155-163 9 p.研究成果: 雜誌貢獻 › 文章
Cartilage
Osteoarthritis
Chondrocytes
Anti-Inflammatory Agents
Chemical activation
Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma
Madamsetty, V. S., Pal, K., Dutta, S. K., Wang, E., Thompson, J. R., Banerjee, R. K., Caulfield, T. R., Mody, K., Yen, Y., Mukhopadhyay, D. & Huang, H-S., 十月 4 2019, 於 : Bioconjugate Chemistry.研究成果: 雜誌貢獻 › 文章
Epidermal Growth Factor Receptor
gemcitabine
Adenocarcinoma
Chemotherapy
Protein-Tyrosine Kinases
A new niclosamide derivatives-B17 can inhibit urological cancers growth through apoptosis-related pathway
Wu, C-L., Chen, C-L., Huang, H-S. & Yu, D-S., 六月 28 2018, 於 : Cancer Medicine.研究成果: 雜誌貢獻 › 文章
Niclosamide
Urologic Neoplasms
Apoptosis
Growth
Control Groups